Lumina: Inflammatory eye disease

A Phase III, Multicenter, Sham-Controlled, Randomized, Double-Masked Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 for the Treatment of Active, Non Infectious Uveitis of the Posterior Segment of the Eye.

 

ADalimumab Versus conventional ImmunoSupprEssion for uveitis (ADVISE) Trial

The ADVISE Trial is a randomized, parallel-treatment, comparative effectiveness trial, comparing adalimumab to conventional (small molecule) immunosuppression for the treatment of non-infectious, intermediate, posterior, and panuveitides. The ADVISE Trial Research Group Funded by the National Eye Institute, the National Institutes of Health.